SPC Financial Inc. grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 315.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 6,228 shares of the healthcare conglomerate's stock after purchasing an additional 4,730 shares during the quarter. SPC Financial Inc.'s holdings in UnitedHealth Group were worth $3,151,000 as of its most recent filing with the SEC.
Several other hedge funds also recently made changes to their positions in UNH. M&T Bank Corp grew its holdings in shares of UnitedHealth Group by 2.3% during the fourth quarter. M&T Bank Corp now owns 225,622 shares of the healthcare conglomerate's stock worth $114,132,000 after buying an additional 5,032 shares during the last quarter. Assetmark Inc. grew its holdings in shares of UnitedHealth Group by 26.4% during the fourth quarter. Assetmark Inc. now owns 135,936 shares of the healthcare conglomerate's stock worth $68,765,000 after buying an additional 28,379 shares during the last quarter. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth about $25,000. J.Safra Asset Management Corp grew its holdings in shares of UnitedHealth Group by 40.1% during the fourth quarter. J.Safra Asset Management Corp now owns 1,889 shares of the healthcare conglomerate's stock worth $959,000 after buying an additional 541 shares during the last quarter. Finally, Cookson Peirce & Co. Inc. lifted its position in UnitedHealth Group by 4.4% in the fourth quarter. Cookson Peirce & Co. Inc. now owns 2,375 shares of the healthcare conglomerate's stock valued at $1,201,000 after purchasing an additional 100 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.
In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business's stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.33% of the stock is owned by corporate insiders.
Shares of NYSE UNH opened at $474.58 on Wednesday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The firm has a fifty day moving average of $515.18 and a 200-day moving average of $555.37. The stock has a market capitalization of $436.74 billion, a PE ratio of 30.62, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same period in the previous year, the company earned $5.83 EPS. The business's quarterly revenue was up 6.8% compared to the same quarter last year. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.77%. UnitedHealth Group's dividend payout ratio (DPR) is 54.19%.
A number of equities research analysts recently commented on the stock. HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. KeyCorp reiterated an "overweight" rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a research report on Tuesday, December 3rd. Finally, Truist Financial reduced their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $629.32.
Read Our Latest Stock Report on UNH
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.